[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100291266":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":32,"responsibleParty":48,"collaborators":20,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":20,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":72,"overallStatus":34,"whyStopped":20,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"King Chulalongkorn Memorial Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Furosemide","EXPERIMENTAL","Single dose of furosemide 1.5 mg\u002Fkg intravenously will be given to all participants at 3 hours post-reperfusion of kidney allograft.\n\nUrine output will be recorded hourly for 6 hours.",[13],"Drug: Furosemide Injection",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Furosemide Injection","Furosemide 1.5 mg\u002Fkg intravenously at 3 hours post-reperfusion of kidney allograft",[9],null,[22],{"name":23,"affiliation":24,"role":25},"suwasin udomkarnjananun, M.D.","King Chulalongkorn Memorial Hospital and Chulalongkorn University","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Suwasin udomkarnjananun, M.D.","CONTACT","66899679885","suwasin.u@gmail.com",[33],{"facility":5,"status":34,"city":35,"state":20,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Bangkok","10330","Thailand","TH",{"type":40,"coordinates":41},"Point",[42,43],100.50144,13.75398,{"lat":43,"lon":42},[46],{"name":47,"role":29,"phone":30,"phoneExt":20,"email":31},"Suwasin Udomkarnjananun, M.D.",{"type":25,"investigatorFullName":49,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Suwasin Udomkarnjananun","100291266","furosemide-stress-test-predicting-early-graft-function-in-kidney-transplantation-100291266",false,"NCT03071536","Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation","Furosemide Stress Test as a Marker of Postoperative Kidney Allograft Function","FOSTIK","Inclusion Criteria:\n\n* Deceased donor kidney transplantation at KCMH\n* informed consent is accepted\n\nExclusion Criteria:\n\n* Known allergy to furosemide\n* Surgical complication of allograft\n* Urgently needed for dialysis (refractory hypervolemia, uremic symptoms, and hyperkalemia)","ALL","18 Years","80 Years",{"count":62,"type":63},180,"ESTIMATED","INTERVENTIONAL",[66],"NA","Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.",[69,70,71],"Kidney Function","Kidney Transplant; Complications","Delayed Graft Function",[73,74,75,76,77],"furosemide stress test","kidney transplantation","urine output","perioperation","delayed graft function","2024-01-15",{"date":80,"type":81},"2024-01-17","ACTUAL",{"date":83,"type":81},"2016-11-25",{"date":85,"type":63},"2027-05",{"name":5,"class":6},1]